BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34887873)

  • 1. A Novel Germline Heterozygous
    Lu HY; Sertori R; Contreras AV; Hamer M; Messing M; Del Bel KL; Lopez-Rangel E; Chan ES; Rehmus W; Milner JD; McNagny KM; Lehman A; Wiest DL; Turvey SE
    Front Immunol; 2021; 12():788278. PubMed ID: 34887873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
    Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
    Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
    Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
    N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.
    Qiao F; Wang C; Luo C; Wang Y; Shao B; Tan J; Hu P; Xu Z
    Mol Genet Genomic Med; 2019 Sep; 7(9):e897. PubMed ID: 31347296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5
    Hatano S; Murakami T; Noguchi N; Yamada H; Yoshikai Y
    Cell Rep; 2017 Oct; 21(5):1191-1202. PubMed ID: 29091759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel variant in BCL11B in an individual with neurodevelopmental delay: A case report.
    Yu Y; Jia X; Yin H; Jiang H; Du Y; Yang F; Yang Z; Li H
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2132. PubMed ID: 36683525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bcl11b
    Matsumoto K; Okuyama K; Sidwell T; Yamashita M; Endo T; Satoh-Takayama N; Ohno H; Morio T; Rothenberg EV; Taniuchi I
    Front Immunol; 2024; 15():1363704. PubMed ID: 38495886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
    Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
    Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.
    Grabarczyk P; Winkler P; Delin M; Sappa PK; Bekeschus S; Hildebrandt P; Przybylski GK; Völker U; Hammer E; Schmidt CA
    Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
    Fahey L; Donohoe G; Broin PÓ; Morris DW
    Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: A Novel Synonymous ARPC1B Gene Mutation Causes a Syndrome of Combined Immunodeficiency, Asthma, and Allergy With Significant Intrafamilial Clinical Heterogeneity.
    Papadatou I; Marinakis N; Botsa E; Tzanoudaki M; Kanariou M; Orfanou I; Kanaka-Gantenbein C; Traeger-Synodinos J; Spoulou V
    Front Immunol; 2021; 12():634313. PubMed ID: 33679784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
    Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
    Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.
    Sidwell T; Rothenberg EV
    Front Immunol; 2021; 12():669498. PubMed ID: 33936112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further validation of craniosynostosis as a part of phenotypic spectrum of BCL11B-related BAFopathy.
    Pande S; Mascarenhas S; Venkatraman A; Bhat V; Narayanan DL; Siddiqui S; Bielas S; Girisha KM; Shukla A
    Am J Med Genet A; 2023 Aug; 191(8):2175-2180. PubMed ID: 37337996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?
    Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ
    Neurotox Res; 2016 Feb; 29(2):201-7. PubMed ID: 26563995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.
    Albu DI; VanValkenburgh J; Morin N; Califano D; Jenkins NA; Copeland NG; Liu P; Avram D
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6211-6. PubMed ID: 21444811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
    Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
    Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
    Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the transcription factor Bcl11b in development and lymphomagenesis.
    Kominami R
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.